Insys therapeutics, inc. (INSY)
Income statement / Quarterly
Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12
Net revenue

7,630

16,357

18,346

23,466

23,911

-

30,670

42,576

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net revenue

-

-

-

-

-

-

-

-

35,962

-

57,773

69,221

60,421

93,914

88,517

80,200

67,692

63,479

58,281

55,696

41,636

40,198

29,211

18,821

11,059

-

-

-

-

Net revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,752

3,539

2,026

Cost of revenue

4,575

2,624

2,379

3,596

2,204

4,611

7,472

3,921

4,639

9,805

4,677

6,273

4,638

6,467

7,707

8,305

6,375

5,860

5,390

6,555

4,773

5,211

3,096

2,594

1,764

2,060

1,948

2,341

1,278

Gross profit

3,055

13,733

15,967

19,870

21,707

26,874

23,198

38,655

31,323

45,055

53,096

62,948

55,783

87,447

80,810

71,895

61,317

57,619

52,891

49,141

36,863

34,987

26,115

16,227

9,295

3,099

2,804

1,198

748

Operating expenses:
Sales and marketing

4,119

5,884

7,358

9,079

9,051

7,095

12,825

13,292

15,658

13,498

16,662

19,691

19,800

18,549

19,217

21,986

20,916

17,349

15,061

14,077

11,618

10,471

7,969

6,331

4,423

3,180

2,899

2,928

2,404

Research and development

10,523

14,356

14,483

16,473

12,260

16,365

19,552

14,103

12,934

15,473

16,516

22,889

19,035

16,061

12,322

17,796

10,602

12,921

7,018

9,189

4,008

3,151

1,737

1,921

1,690

658

1,119

1,696

2,832

General and administrative

10,986

9,935

8,906

10,875

9,552

9,492

11,310

10,643

15,042

-4,177

17,653

13,924

14,698

21,838

12,580

15,284

13,246

14,236

10,790

10,689

8,568

6,949

4,274

2,787

2,362

2,579

2,267

1,845

1,479

Legal

25,677

16,517

16,009

11,148

10,337

-

4,404

6,483

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Charges related to litigation award and settlements

73,863

16,007

30

0

740

-

150,850

4,450

-

-

-

-

-

0

312

2,304

8,000

-

0

0

-

-

-

-

-

-

-

-

-

Total operating expenses

125,168

62,699

46,786

47,575

41,940

47,535

198,941

48,971

43,634

48,688

50,831

56,504

53,533

56,448

44,431

57,370

52,764

44,506

32,869

33,955

24,194

20,571

13,980

11,039

8,475

11,820

6,285

6,469

6,715

Operating loss

-122,113

-48,966

-30,819

-27,705

-20,233

-20,661

-175,743

-10,316

-12,311

-3,633

2,265

6,444

2,250

30,999

36,379

14,525

8,553

13,113

20,022

15,186

12,669

14,416

12,135

5,188

820

-8,721

-3,481

-5,271

-5,967

Other income (expense):
Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

272

673

694

679

673

638

Interest income

423

514

483

484

503

471

510

465

435

277

281

256

225

144

128

105

125

76

43

26

6

-

8

-

-

-

-

-

-

Other expense, net

-908

-196

0

-3

-469

-1

-83

13

26

15

0

-5

49

-

-37

30

-

-11

0

0

13

-32

-24

6

-4

2,342

-90

-424

-82

Total other income (expense)

-485

318

483

481

34

470

427

478

461

292

281

251

274

187

91

135

125

65

43

26

19

-23

-16

-266

-677

-

-

-

-

Loss before income taxes

-122,598

-48,648

-30,336

-27,224

-20,199

-20,191

-175,316

-9,838

-11,850

-3,341

2,546

6,695

2,524

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income (loss) before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

36,470

14,660

8,678

-

20,065

15,212

12,688

14,393

12,119

4,922

143

-7,073

-4,250

-6,368

-6,687

Income tax expense

1,246

-2,355

158

126

171

25,656

-9,036

-1,654

-5,326

311

-379

668

234

13,043

11,840

5,247

2,811

5,752

8,560

5,747

5,030

-9,707

532

375

0

0

0

0

0

Net loss

-123,844

-46,293

-30,494

-27,350

-20,370

-45,847

-166,280

-8,184

-6,524

-3,652

2,925

6,027

2,290

18,143

24,630

9,413

5,867

7,426

11,505

9,465

7,658

24,100

11,587

4,547

143

-7,073

-4,250

-6,368

-6,687

Unrealized gain (loss) on available-for-sale securities, net of tax of $27 and $0

93

80

89

112

-112

-200

13

-24

75

-228

-158

70

166

-185

50

-21

28

-4

-15

13

-18

-

-

-

-

-

-

-

-

Total comprehensive loss

-123,751

-46,213

-30,405

-27,238

-20,482

-46,047

-166,267

-8,208

-6,449

-3,880

2,767

6,097

2,456

17,958

24,680

9,392

5,895

7,422

11,490

9,478

7,640

24,100

11,587

4,547

143

-

-

-

-

Net loss per common share:
Net income (loss) allocable to preferred stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,123

Net income (loss) allocable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-564

Basic

-1.66

-0.62

-0.41

-0.37

-0.28

-0.64

-2.28

-0.11

-0.09

-0.04

0.04

0.08

0.03

0.26

0.34

0.13

0.08

-0.02

0.17

0.14

0.23

0.23

0.36

0.18

0.01

-0.76

-0.46

-0.68

-0.72

Diluted

-1.66

-0.62

-0.41

-0.37

-0.28

-0.64

-2.28

-0.11

-0.09

-0.05

0.04

0.08

0.03

0.25

0.32

0.12

0.08

-0.01

0.16

0.13

0.21

0.18

0.34

0.17

0.01

-0.76

-0.46

-0.68

-0.72

Weighted average common shares outstanding
Basic

74,426

74,374

74,254

73,920

73,745

73,621

72,810

72,169

71,945

71,782

71,640

71,543

71,592

72,030

71,905

71,517

70,916

103,639

69,233

68,596

33,566

136,201

32,107

24,972

14,077

17,848

9,314

9,314

786

Diluted

74,426

74,374

74,254

73,920

73,745

73,621

72,810

72,169

71,945

73,822

74,328

74,053

74,462

76,442

75,991

75,478

74,918

110,635

73,128

72,673

36,902

153,935

34,183

26,058

15,700

17,848

9,314

9,314

786